Goldman Sachs
GOSS icon

Goldman Sachs’s Gossamer Bio GOSS Stock Holding History

Goldman Sachs’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$186K Sell
14,106
-651
-4% -$14.5K ﹤0.01% 6217
2026
Q1 		$388K Sell
14,757
-7,644
-34% -$961K ﹤0.01% 5755
2025
Q4 		$5.56M Buy
22,401
+18,656
+498% +$4.26M ﹤0.01% 3658
2025
Q3 		$788K Buy
3,745
+1,736
+86% +$306K ﹤0.01% 5198
2025
Q2 		$198K Sell
2,009
-9,736
-83% -$850K ﹤0.01% 5668
2025
Q1 		$1.03M Buy
11,745
+10,313
+720% +$954K ﹤0.01% 4667
2024
Q4 		$104K Sell
1,432
-7,702
-84% -$528K ﹤0.01% 5759
2024
Q3 		$721K Sell
9,134
-17,337
-65% -$1.33M ﹤0.01% 4851
2024
Q2 		$1.91M Sell
26,471
-7,204
-21% -$431K ﹤0.01% 3958
2024
Q1 		$3.18M Sell
33,675
-403
-1% -$35.5K ﹤0.01% 3499
2023
Q4 		$2.49M Buy
34,078
+13,272
+64% +$784K ﹤0.01% 3756
2023
Q3 		$1.39M Buy
20,806
+15,758
+312% +$1.45M ﹤0.01% 4030
2023
Q2 		$485K Sell
5,048
-11,600
-70% -$1.16M ﹤0.01% 4768
2023
Q1 		$1.68M Sell
16,648
-5,462
-25% -$836K ﹤0.01% 3998
2022
Q4 		$3.84M Buy
22,110
+8,966
+68% +$5.91M ﹤0.01% 3406
2022
Q3 		$12.6M Buy
13,144
+5,137
+64% +$5.1M ﹤0.01% 2298
2022
Q2 		$5.36M Buy
8,007
+2,308
+40% +$1.43M ﹤0.01% 3067
2022
Q1 		$3.96M Buy
5,699
+2,648
+87% +$2.04M ﹤0.01% 3568
2021
Q4 		$2.76M Sell
3,051
-4,098
-57% -$3.89M ﹤0.01% 3968
2021
Q3 		$7.19M Buy
7,149
+754
+12% +$555K ﹤0.01% 3027
2021
Q2 		$4.15M Sell
6,395
-5,819
-48% -$4.04M ﹤0.01% 3506
2021
Q1 		$9.04M Buy
12,214
+1,560
+15% +$1.26M ﹤0.01% 2657
2020
Q4 		$8.24M Buy
10,654
+514
+5% +$405K ﹤0.01% 2620
2020
Q3 		$10.1M Buy
10,140
+7,973
+368% +$8.46M ﹤0.01% 2320
2020
Q2 		$2.25M Buy
2,167
+1,238
+133% +$1.25M ﹤0.01% 3373
2020
Q1 		$754K Sell
929
-303
-25% -$317K ﹤0.01% 3945
2019
Q4 		$1.54M Buy
+1,232
New +$1.99M ﹤0.01% 3835
2019
Q2 		– Sell
-1,244
Closed -$2.16M – 5213
2019
Q1 		$2.16M Buy
+1,244
New +$2.08M ﹤0.01% 3598

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Goldman Sachs's GOSS Position: Q2 2026 in Review

Goldman Sachs reduced its Gossamer Bio (GOSS) stake by 4.4% in Q2 2026, selling an estimated $14.5K and leaving 14,106 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #6217.

Goldman Sachs first reported a position in GOSS in Q1 2019 and has held it in 28 quarters since. The position peaked at $12.6M in Q3 2022. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Goldman Sachs held 14,106 shares of Gossamer Bio worth $186K as of Q2 2026.
  • Goldman Sachs sold 651 Gossamer Bio shares in Q2 2026, an estimated $14.5K.
  • Gossamer Bio made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6217 holding.
  • Goldman Sachs first reported a position in Gossamer Bio in Q1 2019 and has held it in 28 quarters since.
  • Goldman Sachs's Gossamer Bio position peaked at $12.6M in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.